| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 88,400 | $1 | $353.6K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,900 | $30 | $336.6K |
| J3262 | Injection, tocilizumab, 1 mg | 27,440 | $10 | $137.2K |
| J9312 | Injection, rituximab, 10 mg | 2,070 | $60 | $132.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 10,650 | $10 | $106.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 770 | $90 | $70.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,330 | $20 | $53.6K |
| J0897 | Injection, denosumab, 1 mg | 1,620 | $20 | $29.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 430 | $70 | $28K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 280 | $50 | $14.3K |